Prestige Brands Shows International Ambition Extends To Asia In Australia’s Care Pharmaceuticals Buy
This article was originally published in PharmAsia News
Executive Summary
The acquisition of Australian OTC firm Care Pharmaceuticals brings Prestige Brands a portfolio of pediatric and women’s health products, as well as potential entrée into additional Asia Pacific markets.
You may also be interested in...
In Brief
FDA seeks DMAA product seizure; skin tag remover study flawed – ERSP; Plan B One-Step approved fully OTC; FDA continues evaluating laxative TEA; FDA hosts supply chain public hearing; energy drink marketing to youths challenged; more news In Brief.
Rapidly Growing Prestige Brands Still Positioned For OTC Pickups
The company says it successfully integrated the OTC portfolio acquired from GlaxoSmithKline and is using free cash flow to trim its debt load in the wake of the debt-financed $660 million deal. Prestige reported Q1 net sales up 54.7%, including 4.2% organic growth in OTC health care.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.